1. null
    John R. Šedý et al, 2019 CrossRef
  2. Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer
    Seiji Oguro et al, 2015, Cancer Sci CrossRef
  3. Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1
    Amer Assal et al, 2015, Immunotherapy CrossRef
  4. Investigation of BTLA tagging variants with risk of esophagogastric junction adenocarcinoma
    Weifeng Tang et al, 2019 CrossRef
  5. BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
    Clemence Demerlé et al, 2021, Front. Oncol. CrossRef
  6. Genetic signature of CTLA-4, BTLA, TIM-3 and LAG-3 molecular expression in colorectal cancer patients: Implications in diagnosis and survival outcomes
    Amany M. Kamal et al, 2021, Clinical Biochemistry CrossRef
  7. The prospective prognostic value of the immune checkpoint BTLA expression in adult acute myeloid leukemia patients
    Sara M. Radwan et al, 2021, Egypt J Med Hum Genet CrossRef
  8. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study.
    Ping'an Ding et al, 2022, BMC Gastroenterol CrossRef
  9. Role of BTLA/HVEM network in development of gastric cancer
    Maryam Azarafza et al, 2022, Human Immunology CrossRef
  10. Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2
    Tian-You Cheng et al, 2022, Cells CrossRef
  11. The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
    Anna Andrzejczak et al, 2023, Front. Immunol. CrossRef
  12. Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
    Ping’an Ding et al, 2023, BMC Gastroenterol CrossRef
  13. BTLA biology in cancer: from bench discoveries to clinical potentials
    Anna Andrzejczak et al, 2024, Biomark Res CrossRef
  14. The BTLA-HVEM complex – The future of cancer immunotherapy
    Karolina Wojciechowicz et al, 2024, European Journal of Medicinal Chemistry CrossRef